Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Tumor Radiotherapy Omitting Clinical Target Volume for Patients With Advanced Non Small Cell Lung Cancer Responded to Immunotherapy and Chemotherapy

NCT06037733 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.

NCT NCT06037733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06037733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Tumor Radiotherapy Omitting Clinical Target Volume for Patients With Advanced Non Small Cell Lung Cancer Responded to Immunotherapy and Chemotherapy
Lead sponsor
Hubei Cancer Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 13, 2024
Completion date
October 8, 2027
Enrollment
134 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell squamous lung cancer, immunotherapy, radiotherapy